Back to search

Article

The BTN162b2 Vaccine Induces Humoral and Cellular Immune Memory to Wuhan Strain SARS-CoV-2 and the Omicron Variant in Children 5 to 11 Years of Age

2022-09-12

Abstract excerpt

Background: SARS-CoV-2 infection presents with a wide spectrum of clinical manifestations ranging from mild to severe systemic disease. Recently, due to the spreading of more contagious variants, the number of cases and hospitalizations has also increased in 5-11 year-old children. Although effective vaccines have been approved for administration to children, vaccine acceptance is low. Immunogenicity has been meas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
03fa6d76-af5b-51e5-87e7-895b944f5777
DOI
10.2139/ssrn.4216705
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The BTN162b2 Vaccine Induces Humoral and Cellular Immune Memory to Wuhan Strain SARS-CoV-2 and the Omicron Variant in Children 5 to 11 Years of AgeDOI 10.2139/ssrn.4216705
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVacSemantic proximity
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses Against the SARS-CoV-2 Omicron Variant in Adolescents and AdultsSemantic proximity
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after the third dose of BNT162b2 in healthy adolescentsSemantic proximity
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 YearsSemantic proximity
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron VariantSemantic proximity
Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variantSemantic proximity
Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV) Vaccinated Individuals in a Group of Venezuelan Admixed VolunteersSemantic proximity
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 OmicronSemantic proximity
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 StudySemantic proximity
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenSemantic proximity
Evaluation of T Cell Immune Memory Response after Sinopharm (BBIBP-CorV), Gam-COVID-Vac (Sputnik V), and Heterologous Sputnik-V/mRNA-1273 (Moderna) COVID-19 Vaccination Schemes against Different SARS-CoV-2 VariantsSemantic proximity
Safety and Cross-Reactive Immune Response Against the Omicron Variant of a Third Dose of CoronaVac, and Immune Persistence of Primary Immunization in Healthy Children and Adolescents: Interim Results from a Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical TrialSemantic proximity
Select a neighboring publication to make it the new centre.